Gates Foundation – Icosavax, COVID-19 Vaccine Global Access and Price Commitments Agreement Post author:GHIAA Admin Post published:August 11, 2022 Post category: Continue ReadingGates Foundation – Icosavax, COVID-19 Vaccine Global Access and Price Commitments Agreement
NIH – MPP (C-TAP), COVID-19 Technologies, Patent and Biological Material License Agreement Post author:GHIAA Admin Post published:June 29, 2022 Post category: Continue ReadingNIH – MPP (C-TAP), COVID-19 Technologies, Patent and Biological Material License Agreement
Elkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement Post author:GHIAA Admin Post published:May 27, 2022 Post category: Continue ReadingElkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement
Cellscript – BioNTech mRNA Technology Patent Sublicense Post author:GHIAA Admin Post published:March 17, 2022 Post category: Continue ReadingCellscript – BioNTech mRNA Technology Patent Sublicense
Biological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement Post author:GHIAA Admin Post published:March 2, 2022 Post category: Continue ReadingBiological E – Dynavax Technologies, COVID-19 Vaccine Adjuvant Supply Agreement
Gavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement Post author:GHIAA Admin Post published:February 1, 2022 Post category: Continue ReadingGavi Alliance – Novavax, COVID-19 Vaccine Advance Purchase Agreement
CEPI – Dynavax, COVID-19 Material Reservation Agreement Post author:GHIAA Admin Post published:January 28, 2022 Post category: Continue ReadingCEPI – Dynavax, COVID-19 Material Reservation Agreement
Ocugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement Post author:GHIAA Admin Post published:December 21, 2021 Post category: Continue ReadingOcugen-BBIL, COVID-19 Vaccine (Covaxin), Co-development, Supply & Commercialization Agreement
Moderna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement Post author:GHIAA Admin Post published:November 18, 2021 Post category: Continue ReadingModerna – Lonza, COVID-19 mRNA Vaccine & Therapies, Manufacturing & Process Development Agreement